Amgen Inc.
AMGN
$369.53
$1.930.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.37B | 9.14B | 8.77B | 7.87B | 8.72B |
| Total Other Revenue | 499.00M | 420.00M | 408.00M | 276.00M | 370.00M |
| Total Revenue | 9.87B | 9.56B | 9.18B | 8.15B | 9.09B |
| Cost of Revenue | 2.68B | 2.74B | 2.67B | 2.61B | 2.71B |
| Gross Profit | 7.19B | 6.81B | 6.51B | 5.54B | 6.37B |
| SG&A Expenses | 1.95B | 1.72B | 1.69B | 1.69B | 1.88B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 82.00M | -71.00M | 68.00M | 30.00M | 172.00M |
| Total Operating Expenses | 6.85B | 6.29B | 6.18B | 5.81B | 6.49B |
| Operating Income | 3.01B | 3.26B | 3.00B | 2.34B | 2.60B |
| Income Before Tax | 1.51B | 3.92B | 1.57B | 1.97B | 782.00M |
| Income Tax Expenses | 181.00M | 705.00M | 136.00M | 243.00M | 155.00M |
| Earnings from Continuing Operations | 1.33B | 3.22B | 1.43B | 1.73B | 627.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.33B | 3.22B | 1.43B | 1.73B | 627.00M |
| EBIT | 3.01B | 3.26B | 3.00B | 2.34B | 2.60B |
| EBITDA | 4.02B | 4.57B | 4.35B | 3.73B | 3.89B |
| EPS Basic | 2.47 | 5.98 | 2.66 | 3.22 | 1.17 |
| Normalized Basic EPS | 2.91 | 3.16 | 2.75 | 1.93 | 2.23 |
| EPS Diluted | 2.46 | 5.93 | 2.65 | 3.20 | 1.16 |
| Normalized Diluted EPS | 2.89 | 3.14 | 2.74 | 1.92 | 2.21 |
| Average Basic Shares Outstanding | 539.00M | 538.00M | 538.00M | 538.00M | 537.00M |
| Average Diluted Shares Outstanding | 543.00M | 542.00M | 541.00M | 541.00M | 542.00M |
| Dividend Per Share | 2.38 | 2.38 | 2.38 | 2.38 | 2.25 |
| Payout Ratio | 96.25% | 39.86% | 89.39% | 73.93% | 192.19% |